alexa Antiretrovirals|OMICS International|Virosomes

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Virosomes

Journal of Antivirals & Antiretroviral is one of the renowned top access journals in the field of virology. This journal is a top leading podium for gaining and exchanging knowledge about novel research done in the associated field of virology. The current study mainly involves the discovery and development of antiretroviral drugs, compounds, and clinical methods to prevent viral infections and their spread. Importantly, it provides the opportunity to spread great knowledge to researchers, clinicians, and others working in the field of antiviral drugs and antiretroviral therapies. Antivirals & antiretroviral is an internationally recognized journal for scientists involved in basic, applied, and clinical aspects of virology research. It is known that many viruses emerge and re-emerge threatening both animal and human populations. Antiviral Drug finding is the procedure through which numerous potential and inventive new solutions are recognized to cure HIV contamination. It fundamentally mulls over a wide extend of exploratory orders which incorporates Biology, science and drug store. Viral diseases with restricted or no medication alternatives can represent a significant worldwide wellbeing danger A virosome is a drug or vaccine delivery mechanism consisting of unilamellar phospholipid membrane it may be mono- or bi-layered. Vesicle incorporating virus derived proteins to allow the virosomes to fuse with target cells. Virosomes are not able to replicate but are pure fusion-active vesicles. The development of safe and effective models for the delivery of any prophylactic or therapeutic agent remains an uphill task for pharmaceutical formulation developers. Drug molecules, nucleic acids, carbohydrates, proteins and a variety of other biological and chemical entities are used for attaining pharmacological benefits. However, the major challenge remains in the delivery of these agents to the specific site of action in a time-efficient manner. Among the many drug delivery systems developed, the nano scale technology of virosomes tends to present an established system of delivering the therapeutic agents to the site of pharmacological action. Virosomes are lipid bilayer, unilamellar structures that present viral protein on their surface. They are safe, biocompatible and biodegradable structures that can achieve ideal pharmacological profile once administered into the body. Tissue targeting, immune activation and potentiation are the chief advantages that make them efficient prophylactic and therapeutic agents. The review presents the biopharmaceutical applications of virosomes and the immunological and pharmaceutical considerations that make them efficient agents for targeting spatiotemporal parameters in the body.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top